Search results
Results from the WOW.Com Content Network
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
This logo image consists only of simple geometric shapes or text. It does not meet the threshold of originality needed for copyright protection, and is therefore in the public domain. Although it is free of copyright restrictions, this image may still be subject to other restrictions.
Margins matter. The more AmerisourceBergen (NYS: ABC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to ...
For premium support please call: 800-290-4726 more ways to reach us
This page was last edited on 31 August 2023, at 09:27 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...
The more AmerisourceBergen (NYS: ABC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy ...
Over the past 12 months, AmerisourceBergen generated $1,192.0 million cash while it booked net income of $559.0 million. That means it turned 1.5% of its revenue into FCF. That doesn't sound so great.
Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen. Early life. Collis was born in South Africa and attended the University of Witwatersrand, where he earned a Bachelor of Commerce. Collis is Jewish. Career